End-of-day quote
Other stock markets
|
||
- USD | - |
08/05 | Earnings Flash (INVA) INNOVIVA Posts Q1 Revenue $77.5M | MT |
08/05 | Innoviva, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 301M 25.11B | Sales 2025 * | 334M 27.87B | Capitalization | 974M 81.33B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 3.86 x |
Net Debt 2024 * | 187M 15.64B | Net Debt 2025 * | 106M 8.87B | EV / Sales 2025 * | 3.24 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 65.49% |
Latest transcript on Theravance Inc
Managers | Title | Age | Since |
---|---|---|---|
Pavel Raifeld
CEO | Chief Executive Officer | 40 | 20/20/20 |
Stephen Basso
DFI | Director of Finance/CFO | 58 | 21/23/21 |
Marianne Zhen
AUD | Comptroller/Controller/Auditor | 55 | 01/14/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 64 | 12/18/12 | |
Director/Board Member | 53 | 01/23/01 | |
Jules Haimovitz
BRD | Director/Board Member | 73 | 12/18/12 |
1st Jan change | Capi. | |
---|---|---|
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |